|
KMID : 1048120140030010024
|
|
International Journal of Gastrointestinal Intervention
2014 Volume.3 No. 1 p.24 ~ p.26
|
|
|
Endoscopic ultrasound-guided immunotherapy
|
|
Irisawa Atsushi
Shibukawa Goro
Takagi Tadayuki
Abe Yoko
Saito Akiko
Imbe Koh
Hoshi Koki
Yamabe Akane
Igarashi Ryo
|
|
|
Abstract
|
|
|
|
Anti-tumoral endoscopic ultrasound-guided fine-needle injection (EUS-FNI), with its minimally invasive access for anti-tumoral agent delivery, is the most exciting field of intervention EUS. Pancreatic cancer is regarded as a systemic disease even if imaging modalities reveal no visible metastasis. From that perspective, immunological therapy is performed. To date, several reports have described immunotherapy under EUS-guidance. The first report of EUS-FNI intended for immunotherapy for advanced pancreatic cancer was published in 2000. In that study, an allogeneic mixed-lymphocyte culture was injected into tumors of eight patients with unresectable local pancreatic adenocarcinoma. The study of dendritic cells (DCs) for cancer has continued to develop in recent years. Actually, DCs are potent antigen-presenting cells for the induction of primary T-cell dependent immune response. When injected intratumorally, DCs acquire and process tumor antigens in situ, migrate to regional lymphoid organs, and initiate a strong tumor-specific immune response. To date, three reports have described EUS-FNI of DCs into pancreatic cancer: two for unresectable and one for pre-surgical operations. Every study has indicated the feasibility and safety. Furthermore, these reports showed that EUS-guided DCs injection might be an important option for treating advanced pancreatic cancer. EUS-guided immunotherapy is a very exciting field in interventional EUS for obstinate cancers.
|
|
|
KEYWORD
|
|
|
Dendritic cell, EUS-FNA, EUS-FNI, Endoscopic ultrasound, Immunotherapy
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
|
|